Pilot trial to determine the efficacy of secukinumab in active non-segmental vitiligo
Latest Information Update: 13 Feb 2023
At a glance
- Drugs Secukinumab (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 02 Mar 2018 Status changed from recruiting to completed.
- 14 Jul 2016 New trial record